Salute e Benessere

Ultimovacs ASA: Mandatory notification of trade by primary insider

This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act. Attachment 20231121 - Ultimovacs Notification of trade - CDS - KRT 1500
Nasdaq GlobeNewswire
21/11/2023

Mass Spectrometry Market to Reach $14.6 Billion, Globally, by 2032 at 7.7% CAGR…

Request Sample of the Report on Mass Spectrometry Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/2639 Request Sample of the Report on Mass Spectrometry Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/2639 Prime determinants of growth Technological advancements in the mass spectrometry, increase in research and development activities in biopharmaceutical industry, and surge in the awareness about food safety drive the growth...
PR Newswire
21/11/2023

EDX MEDICAL ANNOUNCES COLLABORATION WITH THERMO FISHER SCIENTIFIC TO DEVELOP…

About Thermo Fisher Scientific About Thermo Fisher Scientific Thermo Fisher Scientific EMEA Ltd is part of Thermo Fisher Scientific Inc. (NYSE: TMO) which is the world leader in serving science, with annual revenue over$40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient...
PR Newswire
21/11/2023

Autoimmune Disease Diagnostics Market size worth $ 9.98 Billion, Globally, by…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=27521 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=27521 Browse in-depth TOCon" Autoimmune Disease Diagnostics Market " 202 - Pages126 – Tables 37 – Figures Autoimmune Disease Diagnostics Market Poised for Remarkable Growth: Key Insights Unveiled Cutting-edge Technology and Initiatives Propel Global Market In a landscape marked by...
PR Newswire
21/11/2023

Diagnostic Imaging Market Size to Grow USD 12630 Million by 2029 at a CAGR of…

Get Free sample: https://reports.valuates.com/request/sample/QYRE-Auto-6Q1648/Global_Diagnostic_Imaging Get Free sample : https://reports.valuates.com/request/sample/QYRE-Auto-6Q1648/Global_Diagnostic_Imaging Major Factors Driving the Growth of Diagnostic Imaging Market The government's increased investment and reimbursement initiatives, the growing demand for early detection tools, the expansion of new facilities by market players in developing nations, the rising prevalence of...
PR Newswire
21/11/2023

Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201…

NEXICART-2 to expand studies of NXC-201 in relapsed/refractory AL Amyloidosis to U.S. sites based on IND clearance 72 patients previously dosed with NXC-201 ex-U.S.First CAR-T program for light-chain (AL) AmyloidosisFavorable tolerability enables expansion into autoimmune indications LOS ANGELES, Nov.21, 2023(GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq:IMMX) (“ImmixBio”, “Company”, “We” or “Us”), a clinical-stage biopharmaceutical company advancing personalized therapies for...
Nasdaq GlobeNewswire
21/11/2023

Alvotech to Report Financial Results for the First Nine Months of 2023 on…

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results for the first nine months of 2023, after U.S. markets close on Tuesday, November 28, 2023.Following the release, Alvotech will conduct a business update conference call for analysts on Wednesday, November 29, 2023, at 8:00 am ET (1 pm GMT). Live audio of the conference call will be webcast and...
Nasdaq GlobeNewswire
21/11/2023

iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference

thAnnual Healthcare Conference in New York City on Tuesday, November 28, 2023 at 1:30 p.m. ET. A live webcast of the event will be available on the Investor section of the Company's website at https://www.iteostherapeutics.com. An archived replay will be available for approximately 30 days following the presentation. About iTeos Therapeutics, Inc. iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of...
Nasdaq GlobeNewswire
21/11/2023

Bulletin from the extraordinary general meeting in Immunovia AB

The meeting resolved, in accordance with the nomination committee's proposal, (i) that the number of board members shall be six, with no deputy members, and (ii) to elect Melissa Farina and Valerie Bogdan-Powers as new board members. For the time up until the next annual general meeting, the board will consist of Peter Høngaard Andersen (chair), Hans Johansson, Michael Löfman, Martin Møller, Melissa Farina and Valerie Bogdan-Powers. The meeting resolved, in accordance with the nomination...
PR Newswire
21/11/2023

Lush is encouraging users to ESC Big Tech with latest campaign

With over 100 organisations, People vs Big Tech is taking on the outsized power of the Big Tech giants and helping secure groundbreaking victories, like sweeping new tech laws in Europe. With new laws passing in the UK and Europe providing a once-in-a-generation opportunity to curb the Big Tech companies in Europe, the importance of communities in shaping regulation has never been more important, especially mobilising the youth. With over 100 organisations, People vs Big Tech is taking on...
PR Newswire
21/11/2023

Menarini Group Announces New Data on ORSERDU® (elacestrant) at the 2023 San…

- ELZONRIS presentation includes updated real-world data from patients with Blastic Plasmacytoid Dendritic Cell Neoplasm -ELZONRIS presentation includes updated real-world data from patients with Blastic Plasmacytoid Dendritic Cell Neoplasm FLORENCE, Italy and NEW YORK,Nov. 21, 2023/PRNewswire/ -- The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini…
PR Newswire
21/11/2023

Biocomposites expands its product portfolio with the launch of SYNICEM™ spacers…

The launch of SYNICEMTM spacers in the UK follows Biocomposites' acquisition of French-based medical device manufacturer, Synimed, in 2022. Synimed specialises in bone cement and polymer related products using in-house proprietary core polymer production and formulation. The launch of SYNICEM TMspacers in the UK follows Biocomposites' acquisition of French-based medical device manufacturer, Synimed, in 2022. Synimed specialises in bone cement and polymer related products using in-house...
PR Newswire
21/11/2023

Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and…

Frans Cromme, Chief Executive Officer of ViCentra, said: "We aim to deliver the best user experience as well as excellent clinical results with our Kaleido insulin pump and our partners. Kaleido with DBLG1 and Dexcom G6 improves users' Time in Range by 16.7%1, an achievement that should bring real benefits to people with type 1 diabetes. We are proud to deliver this game changing technology via a beautiful and small device, as we feel people deserve this when they need to rely on a medical…
PR Newswire
21/11/2023

Implantica's RefluxStopTM, a promising new procedure for chronic acid reflux…

Approximately 20% of the adult UK population have problems with severe acid reflux[1] or GORD. For some, GORD is chronic and can cause severe pain, regurgitation, swallowing difficulties, cough, asthma, insomnia, voice loss, teeth and gum damage, nutritional problems and depression. Approximately 20% of the adult UK population have problems with severe acid reflux [1]or GORD. For some, GORD is chronic and can cause severe pain, regurgitation, swallowing difficulties, cough, asthma, insomnia,...
PR Newswire
21/11/2023

Healthcare Executive Angela Single Joins Novari Health

Angela's clinical background is in acute oncology as a qualified community nurse. She previously held the positions of general manager for all acute services at Hinchingbrooke Healthcare NHS Trust (now North West Anglia Foundation Trust) and deputy chief nurse at North Middlesex University NHS Trust. Angela's clinical background is in acute oncology as a qualified community nurse. She previously held the positions of general manager for all acute services at Hinchingbrooke Healthcare NHS…
PR Newswire
21/11/2023

ScreenPoint Medical Hits New Milestones

Used by hundreds of sites globally, Transpara has set the standard for Breast AI, supporting all major mammography gantry manufacturers, and integrating into radiology reading workflow both in the single-reading and double-reading environments. ScreenPoint will showcase its industry leading Transpara results at the upcoming 109 thAnnual Radiological Society ofNorth America(RSNA) meeting,November 26-30, 2023(South Hall #3947). The clinical and workflow benefits of...
PR Newswire
21/11/2023

Phase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov…

ORION CORPORATIONINVESTOR NEWS21 NOVEMBER 2023 at 08:30 EET Phase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov databaseTwo new Phase 3 clinical trials to evaluate the safety and efficacy of ODM-208 for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) have been posted to the ClinicalTrials.gov website. The studies are not yet recruiting patients. Further information is available on ClinicalTrials...
Nasdaq GlobeNewswire
21/11/2023

United States Patent and Trademark Office (USPTO) Cancels All Claims of Swift…

The decision cancels each of the original claims of the '345 Patent and declares unpatentable each of Swift's proposed substitute claims. Amongst the prior art deemed by the USPTO to render the '345 Patent unpatentable is a patent application licensed to MolecuLight that lists MolecuLight's Founder, Dr. Ralph DaCosta, as the sole inventor. The decision cancels each of the original claims of the '345 Patent and declares unpatentable each of Swift's proposed substitute claims. Amongst the prior...
PR Newswire
21/11/2023

Sandoz launches Hyrimoz® (adalimumab) high-concentration formulation in Europe…

Biosimilar Hyrimoz ®(adalimumab) citrate-free high-concentration formulation (HCF) indicated for all conditions of reference medicine Humira ®* Hyrimoz ®HCF to launch progressively across EuropeHyrimoz ®HCF strengthens well-established Sandoz biosimilar immunology portfolio in EuropeBasel, November 21, 2023– Sandoz, the global leader in generic and biosimilar medicines, today announces the launch of Hyrimoz ®(adalimumab) citrate-free high concentration formulation (HCF; 100...
Nasdaq GlobeNewswire
21/11/2023

Pharming announces first patient dosed in pediatric clinical trial for children…

The multinational Phase III study is evaluating a new pediatric granulated formulation of leniolisib in children aged 1 to 6 years with APDS, a rare primary immunodeficiencyLeiden, The Netherlands, November 21, 2023:Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM)/(Nasdaq: PHAR) announces that the first patient has been dosed in its Phase III pediatric clinical trial evaluating a new pediatric formulation of the investigational drug leniolisib, an oral,...
Nasdaq GlobeNewswire
21/11/2023

High Speed Steels Market to Reach $9.4 Billion, Globally, by 2032 at 6.2% CAGR…

Prime Determinants of Growth Prime Determinants of Growth The high-speed steel market is poised for substantial growth, driven by several key factors. The escalating demand for high-speed steel in the aerospace and energy sectors is a major driver propelling market expansion. Additionally, the surging global energy consumption and a heightened focus on renewable energy projects are expected to further boost the growth of the high-speed steel market. However, lack of investment in...
PR Newswire
21/11/2023

Rising Hydration Awareness and Growing Disposable Income Propel Global Smart…

NEWARK, Del., Nov. 20, 2023 /PRNewswire/ -- In 2022, the market for smart water bottles was valued at US$ 31,229.9 million. The market for such interactive vessels is expanding as more sports fans choose equipment that improves their training. By 2033, sales are expected to be valued at US$ 96,755 million, anticipated to incline at a CAGR of 10.9%. NEWARK, Del.,Nov. 20, 2023/PRNewswire/ -- In 2022, the market for smart water bottles was valued atUS$ 31,229.9 million. The market for...
PR Newswire
20/11/2023

Fabric Odor Eliminators: A Market Driven by Freshness, Expected to Reach US$…

The global fabric odor eliminator market will reach US$ 1,678.60 million in 2024. The fabric odor eliminator sales are expected to witness a robust CAGR of 6.8% from 2024 to 2034. By 2034, the fabric odor eliminator demand is anticipated to reach a valuation of US$ 3,235.20 million. The global fabric odor eliminator market will reachUS$ 1,678.60 millionin 2024. The fabric odor eliminator sales are expected to witness a robust CAGR of 6.8% from 2024 to 2034. By 2034, the fabric odor...
PR Newswire
20/11/2023

Key Market Analysis of Sickle Cell Disease, Fanconi Anemia, and Diamond-Blackfan…

DelveInsight has recently released a series of epidemiology-based market reports focusing on inherited types of anemia including Sickle Cell Disease, Fanconi Anemia, and Diamond-Blackfan Anemia. These reports include a comprehensive understanding of current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032 segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and…
PR Newswire
20/11/2023
Altri  Comunicati